| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8232097 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 6 Pages |
Abstract
The combination of palliative external beam radiation with concurrent weekly bortezomib therapy at a dose of 1.6 mg/m2 is well tolerated in patients with metastatic solid tumors. The maximum tolerated dose of once weekly bortezomib delivered concurrently with radiation therapy is greater than 1.6 mg/m2.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Thomas J. M.D., Changhu M.D., Rachel M.D., S. Gail M.D., Kyle E. M.D., Robyn B.A., David M.D.,